Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial.
Roy S, Sun Y, Morgan SC, Wallis CJD, King K, Zhou YM, D'souza LA, Azem O, Cueto-Marquez AE, Camden NB, Spratt DE, Kishan AU, Saad F, Malone S. Roy S, et al. Among authors: wallis cjd. Eur Urol. 2023 Jun;83(6):571-579. doi: 10.1016/j.eururo.2023.02.017. Epub 2023 Mar 7. Eur Urol. 2023. PMID: 36894488 Clinical Trial.
Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial.
Roy S, Malone S, Sun Y, Zaorsky NG, Spratt DE, Morgan SC, Dess RT, Wallis CJD, Kishan AU, Citrin DE, Saad F. Roy S, et al. Among authors: wallis cjd. Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):119-126. doi: 10.1016/j.ijrobp.2023.10.046. Epub 2023 Nov 3. Int J Radiat Oncol Biol Phys. 2024. PMID: 37924987 Clinical Trial.
Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience.
Ranganathan S, Riveros C, Xu J, Hu S, Geng M, Huang E, Melchiode Z, Zhang J, Efstathiou E, Chan KS, Wallis CJD, Sonpavde G, Satkunasivam R. Ranganathan S, et al. Among authors: wallis cjd. Urol Oncol. 2024 May 18:S1078-1439(24)00428-9. doi: 10.1016/j.urolonc.2024.04.006. Online ahead of print. Urol Oncol. 2024. PMID: 38763801
Industry Payments to American Editorial Board Members of Major Urology Journals.
Nguyen DD, Murad L, Nguyen AX, Zorigtbaatar A, Bouhadana D, Deyirmendjian C, Zorn KC, Elterman D, Chughtai B, Sayyid RK, Labban M, Trinh QD, Wallis CJD, Bhojani N. Nguyen DD, et al. Among authors: wallis cjd. Eur Urol. 2023 Oct;84(4):442-443. doi: 10.1016/j.eururo.2023.04.017. Epub 2023 Apr 29. Eur Urol. 2023. PMID: 37127467 No abstract available.
Screening and management of metabolic, cardiac, and bone health in prostate cancer patients on androgen deprivation therapy: A survey of specialized physicians.
Nguyen DD, Mousa A, Klotz L, Niazi T, Pouliot F, Kokorovic A, Lavallée LT, Huynh M, Lapointe N, Di Risio M, Wallis CJD. Nguyen DD, et al. Among authors: wallis cjd. Can Urol Assoc J. 2024 Apr 2. doi: 10.5489/cuaj.8687. Online ahead of print. Can Urol Assoc J. 2024. PMID: 38587979 Free article. No abstract available.
Association Between GLP1R Agonists and Prostate, Kidney, and Bladder Cancers.
Bukavina L, Helstrom E, Wallis CJD, Fulmes A, Calaway A, Correa A, Rhodes S. Bukavina L, et al. Among authors: wallis cjd. Eur Urol Oncol. 2024 May 2:S2588-9311(24)00098-1. doi: 10.1016/j.euo.2024.04.006. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38702255 No abstract available.
267 results